Pharma major Dr Reddy's Laboratories on January 25 reported a 77 percent growth in consolidated net profit at Rs 1,247 crore for the quarter ended December 31, 2022 as against Rs 707 crore a year ago. On a sequential basis, the profit grew 12 percent.
The Hyderabad-based drugmaker also reported a 27 percent increase in consolidated revenue at Rs 6,770 crore as against Rs 5,320 crore in the year-ago period, while it was up 7 percent sequentially.
"Our strong financial performance was supported by growth in the US and the Russia markets. We continue to strengthen our development pipeline to reach more patients globally," Co-chairman & MD, G V Prasad, commented on its performance.